Wednesday, August 26, 2026
Via News Knowledge File

Stock Advisor

product100% conf.·synced Aug 13, 2026

Investment advisory service by The Motley Fool

7
sourced metrics
454
relationships
0
stated objectives
0
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Annual Income Boost Claim
23760USD
Benchmark Comparison Return
210percent
Jul 10, 2026source
Market Share
902percent_total_average_return
Jun 30, 2026source
Sp500 Comparison Return
179percent
Mar 28, 2026source
Sp500 Outperformance
183percent
Mar 22, 2026source
Benchmark Return
196percent
Dec 29, 2025source
Return Vs Sp500
4multiple
Mar 3, 2025source

Relationship graph · 454 connections

Developed by
188
subsidiary of
86
Owns
79
Covered by
75
rates
8
product of
4
Competes with
4
offers
2
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com